Microdosing tirzepatide in units Microdosing has gained significant attention as a strategy for minimizing side effects while still receiving therapeutic benefit
Running performance improves
Start your free assessment today to connect with a licensed physician who can guide you toward the most effective weight loss approach for your specific situation
Retatrutide carries the side-effect profile of the GLP-1/GIP class nausea, vomiting, diarrhoea, constipation plus the class-level concerns we know from Mounjaro and Wegovy: gallbladder disease, pancreatitis, kidney injury from severe dehydration, and a possible thyroid C-cell tumour signal seen in rodent studies
You might experience the following symptoms: Nausea or an upset stomach Diarrhea or loose stools Vomiting in some cases Constipation or bloating Reflux or heartburn These symptoms often happen when the dose increases
Three come up consistently in the clinical literature on growth-hormone-axis agents